Nicola Andina
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Ribonuclease inhibitor and angiogenin system regulates cell type-specific global translation.
Journal: Science advances
Published: May 31, 2024
Human molecular genetics sheds light on the physiological significance of ribonuclease inhibitor (RNH1).
Journal: European journal of human genetics : EJHG
Published: March 28, 2023
Increased Inflammasome Activation Is Associated with Aging and Chronic Myelomonocytic Leukemia Disease Severity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 08, 2022
Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature.
Journal: Frontiers in medicine
Published: March 06, 2022
Inflammasome Activation in Myeloid Malignancies-Friend or Foe?
Journal: Frontiers in cell and developmental biology
Published: November 30, 2021
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity.
Journal: Life science alliance
Published: September 06, 2021
The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial.
Journal: Scientific reports
Published: February 18, 2020
Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.
Journal: Seminars in hematology
Published: November 04, 2017
Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation.
Journal: The Journal of clinical investigation
Published: May 15, 2017
RhoH is a negative regulator of eosinophilopoiesis.
Journal: Cell death and differentiation
Published: January 11, 2016
Last Updated: 09/26/2026